Is Oxford Nanopore Technology Ready for Clinical Diagnostics?

Poster   Apr 26, 2017

 
Is Oxford Nanopore Technology Ready for Clinical Diagnostics?
 
View Poster

GR Taylor, Kesia Brown, Andrew Bond & Michael Yau

 
 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License

 
View Poster
 
 
 

OTHER POSTERS

Exploiting Polypharmacology in Precision Oncology: Identification of Differential Kinase Off-targets Among Clinical PARP Inhibitors

Poster

Can we use computational methods to identify previously unknown off-targets of PARP inhibitors that can explain their observed differences?

READ MORE

Validation of an Image-Based 3D Natural Killer Cell Mediated Cytotoxicity Assay

Poster

Here we describe a novel 3D NK cell mediated cytotoxicity (CMC) assay.

READ MORE

Analysis of the Effect of Aggregated β-Amyloid on Cellular Signaling Pathways Critical for Memory in Alzheimer’s Disease

Poster

Here we evaluate the ability to detect changes in phosphorylation levels of ERK and CREB following treatment with Aβ using the SH-SY5Y neuroblastoma cell line.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE